Skip to main content
Fig. 10 | Stem Cell Research & Therapy

Fig. 10

From: Compared to the amniotic membrane, Wharton’s jelly may be a more suitable source of mesenchymal stem cells for cardiovascular tissue engineering and clinical regeneration

Fig. 10

Expression of HSPG and NOS of both WJ-MSC- and AM-MSC-derived cell sheets as well as HUVECs. Mean ± SD of five independent experiments performed in triplicate. * P > 0.05; *** P < 0.001. AM-MSCs amniotic membrane mesenchymal stem cells, eNOS endothelial nitric oxide synthase, HSPG heparin sulfate proteoglycan, HUVECs human umbilical vein endothelial cells, WJ-MSCs Wharton’s jelly mesenchymal stem cells

Back to article page

Stem Cell Research & Therapy

ISSN: 1757-6512